Skip to main content
. 2010 Mar 17;2010(3):CD002233. doi: 10.1002/14651858.CD002233.pub2

Freitas 2000.

Methods Generation of the randomisation list and allocation concealment: method not reported. Lost to the follow‐up period: not reported. Complete results reported only for 104/111 patients. Intention‐to‐ treat‐analysis: no.
Participants Country: Portugal. Cirrhotic patients with endoscopy‐proven non spurting variceal bleeding.
Interventions EVS: intra‐para variceal 0.5 to 1 ml of absolute ethanol (max 12 ml). Octreotide: 48‐h continuous iv infusion of 25 µg/h.
Outcomes 48‐h failure to control bleeding. 7‐day re‐bleeding. 30‐day mortality.
Notes Patients with spurting variceal bleeding were included in a parallel trial of sclerotherapy plus octreotide vs sclerotherapy alone.
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Unclear risk Unclear
Allocation concealment? Unclear risk Unclear